| Description of Lactulose Administration by Balloon Rectal Tube in Severe Hepatic Encephalopathy (NCT06248736) | University Hospital, Grenoble | 2022-06-07 |
| Hepatic Encephalopathy Prevention With Polydextrose After TIPS: Pilot Study (POEME) (NCT05206487) | University Hospital, Toulouse | 2022-05-09 |
| Effect of Brief Dietary Intervention on Ammonia Levels (NCT05376488) | Hunter Holmes Mcguire Veteran Affairs Medical Center | 2022-05-01 |
| Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (NCT05071716) | Bausch Health Americas, Inc. | 2022-04-07 |
| Prediction of Post-TIPS Hepatic Encephalopathy in Patients With Liver Cirrhosis (NCT05466669) | Johannes Gutenberg University Mainz | 2022-03-09 |
| Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhotic Patients (NCT05279586) | Madonna Magdy Fahmy | 2022-03-01 |
| TReatment for ImmUne Mediated PathopHysiology (NCT04862221) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2022-02-09 |
| Efficacy and Safety of Fecal Microbiota Transplant for Secondary Prophylaxis of Hepatic Encephalopathy (NCT05229289) | Institute of Liver and Biliary Sciences, India | 2022-01-31 |
| Deprescribing Proton Pump Inhibitors to Reduce Post-TIPS Hepatic Encephalopathy (NCT05070351) | Duke University | 2022-01-03 |
| Role of Sarcopenia and Nutritional/Physical Therapy Intervention in Post-TIPS Hepatic Encephalopathy (NCT05346029) | Anna Baiges | 2022-01-01 |
| Early Diagnosis and Timely Treatment of Cirrhotic Patients With Minimal Hepatic Encephalopathy (CHESS-NCRCID 2106) (NCT05140837) | Hepatopancreatobiliary Surgery Institute of Gansu Province | 2021-12-09 |
| Integrated Traditional Chinese and Clinical Medicine for Chronic Hepatitis B and Its Complication (NCT05128305) | Qianfoshan Hospital | 2021-12-01 |
| MNK-6105 for Patients With Cirrhosis and High Ammonia Levels Affecting Brain Function (NCT04128462) | Mallinckrodt | 2021-11-01 |
| Speech in Hepatic Encephalopathy (HE) (NCT05425316) | University of Michigan | 2021-10-05 |
| VE303 for Treatment of Hepatic Encephalopathy (HE) (NCT04899115) | Patricia Bloom | 2021-08-06 |
| Efficacy and Safety of AXA1665 in Cirrhotic Subjects With Prior Overt Hepatic Encephalopathy (NCT04816916) | Axcella Health, Inc | 2021-06-29 |
| Feasibility of an App-based Nutrition & Exercise Program in Cirrhosis (NCT05033327) | University of Alberta | 2021-04-20 |
| Fecal Microbiota Transplantation by Oral Capsules for Hepatic Encephalopathy Treatment (NCT06368895) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2021-04-07 |
| Investigational Microbiota Restoration Therapeutic for Hepatic Encephalopathy (NCT04155099) | Ochsner Health System | 2021-03-01 |
| Establishment of the Human Intestinal and Salivary Microbiota Biobank - Gastrointestinal Diseases (NCT04698148) | Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari | 2021-02-08 |
| The BRAINFOOD Trial to Prevent Recurrent Hepatic Encephalopathy. (NCT04675775) | University of Michigan | 2021-01-21 |
| Early Postoperative CRRT After Liver Transplantation in ACLF Patients With Overt HE (NCT04317222) | Third Affiliated Hospital, Sun Yat-Sen University | 2020-06-01 |
| Polyethylene Glycol Versus Lactulose on Hepatic Encephalopathy in Patients With Cirrhosis;(PEGHE Trial) (NCT04436601) | Aga Khan University | 2020-03-09 |
| HepQuant to Predict Hepatic Encephalopathy After TIPS (NCT04664621) | Northwestern University | 2020-02-25 |
| Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose (NCT04073290) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2020-01-21 |
| Diagnosing Minimal Hepatic Encephalopathy (NCT05433948) | Esbjerg Hospital - University Hospital of Southern Denmark | 2019-12-01 |
| Intravenous Branched Chain Amino Acids for Hepatic Encephalopathy in ACLF (NCT04238416) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2019-11-01 |
| Flicker App for Minimal Hepatic Encephalopathy (NCT04415294) | University of Washington | 2019-10-22 |
| Late Evening and Early Morning Protein Supplement to Reduce Readmissions for Hepatic Encephalopathy (NCT04096014) | The Cleveland Clinic | 2019-09-16 |
| Rifamycin in Minimal Hepatic Encephalopathy (NCT04082780) | Hunter Holmes Mcguire Veteran Affairs Medical Center | 2019-09-01 |
| FMT in Cirrhosis and Hepatic Encephalopathy (NCT03796598) | VA Office of Research and Development | 2019-07-29 |
| Safety and Efficacy of Fecal Microbiota Transplantation (NCT04014413) | Chinese University of Hong Kong | 2019-07-15 |
| The Influence of Post-transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy (NCT03825848) | Shanghai Zhongshan Hospital | 2019-06-20 |
| Role of MRI in Detection of Minimal Hepatic Encephalopathy (NCT04131205) | University Medical Centre Ljubljana | 2019-06-01 |
| Coenzyme Q10 and Meclofenoxate in Hepatic Encephalopathy (NCT03961087) | Zagazig University | 2019-05-23 |
| A Study of MHE in Patients With Liver Diseases (NCT04058327) | Qin Ning | 2019-05-01 |
| Efficacy and Safety of Nitazoxanide in Preventing Recurrence of Hepatic Encephalopathy (NCT04161053) | Tanta University | 2018-11-01 |
| HEAL STUDY (Hepatic Encephalopathy and Albumin Study) (NCT03585257) | Hunter Holmes Mcguire Veteran Affairs Medical Center | 2018-06-20 |
| PEG3350 in ACLF With Hepatic Encephalopathy (NCT03987893) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2018-05-20 |
| Tackling 30-day Readmissions in Patients With Cirrhosis: The SALTYFOOD Trial (NCT03493204) | University of Michigan | 2018-04-24 |
| Fecal Microbiota Transplant as Treatment of Hepatic Encephalopathy (NCT03420482) | Massachusetts General Hospital | 2018-04-01 |
| Minimal Hepatic Encephalopathy in Hereditary Hemorrhagic Telangiectasian (NCT03586115) | University of Bari | 2018-01-08 |
| Plasma Free Amino Acids in Patients With Hepatic Encephalopathy (NCT03306498) | Assiut University | 2017-12-15 |
| Diet Management on Hepatic Encephalopathy of Patients With Variceal Bleeding After Intrahepatic Portosystemic Shunt Creation (NCT03372499) | Li Yang | 2017-10-01 |
| Eye Movement Testing for Diagnosing Encephalopathy in Patients With Liver Disease (NCT04940416) | Stanford University | 2017-08-31 |
| Oral Fecal Transplant in Cirrhosis (NCT03152188) | Virginia Commonwealth University | 2017-06-12 |
| PEG (Polyethylene Glycol)Versus Lactulose For Treatment Of Overt Hepatic Encephalopathy (NCT03100513) | Sherief Abd-Elsalam | 2017-03-11 |
| VICIS - Vienna Cirrhosis Study (NCT03267615) | Medical University of Vienna | 2017-02-01 |
| Efficacy and Safety of E.Coli Nissle 1917 in Patients With Mild (Stage 1-2) or Minimal Hepatic Encephalopathy (NCT04787276) | Bogomolets National Medical University | 2017-01-10 |
| The Effect of Induced Hyperammonaemia on Sleep and Melanopsin-mediated Pupillary Light Response in Patients With Liver Cirrhosis (NCT04771104) | Rigshospitalet, Denmark | 2017-01-01 |
| Timing of Acute Palliative Care Consultation in Critically Ill Patients (NCT02858778) | Wayne State University | 2016-06-01 |
| Fecal Transplant for Hepatic Encephalopathy (NCT03439982) | University of Alberta | 2016-04-12 |
| The International Imaging Registry in Liver Cirrhosis (BAVENO-VI SPSS GROUP). (NCT02692430) | Hospital Universitari Vall d'Hebron Research Institute | 2016-04-01 |
| A Retrospective, Open-label, Uncontrolled Cohort Study to Assess the Effectiveness and Safety of Lactulose Retention Enema in the Treatment of Cirrhotic Patients With Grade 3 or 4 (West Haven Criteria) Hepatic Encephalopathy (HE) [The RETRO Study] (NCT02377947) | Abbott | 2015-12-01 |
| Minimal HePatic Encephalopathy Among CiRrhotics. A Cross SEctional, Clinico-EpidEmiological, Multi-Centre, Study in Patients of PakisTan (NCT02613858) | Abbott | 2015-11-01 |
| A Randomized Comparison of Rifaximin Versus Lactulose in Hospitalized Cirrhotic Patients With Renal Failure (NCT02086825) | NYU Langone Health | 2015-10-01 |
| Fecal Transplant in Recurrent Hepatic Encephalopathy (NCT02636647) | Jasmohan Bajaj | 2015-10-01 |
| Real World Outcomes Study of Hepatic Encephalopathy Patients' Experience on Rifaximin (PROSPER) (NCT02488993) | Norgine | 2015-06-01 |
| Albumin Infusion Effects in Mortality in Patients With Cirrhosis and Hepatic Encephalopathy (NCT02401490) | Hospital Universitari Vall d'Hebron Research Institute | 2015-04-01 |
| Microbial Resistance of Rifaximin in Hepatic Encephalopathy (NCT04736836) | National Hepatology & Tropical Medicine Research Institute | 2015-01-01 |
| The Effects of Nitazoxanide in Hepatic Encephalopathy (NCT02334163) | Ain Shams University | 2014-12-01 |
| Effect of Transjugular Intrahepatic Portosystemic Shunt on Gut Microbiota in Cirrhotic Patients (NCT02427906) | West China Hospital | 2014-08-01 |
| Fecal Microbiota Transplantation (FMT) in the Management of Hepatic Encephalopathy (HE): a Pilot Study (NCT02255617) | University of Alberta | 2014-07-23 |
| Lactulose, L-ornithine L-aspartate, or Rifaximin Versus Placebo for Preventing Hepatic Encephalopathy in Variceal Bleeding (NCT02158182) | Hospital General de Mexico | 2014-07-01 |
| Treatment of Hepatic Encephalopathy With Flumazenil and Change in Cortical GABA Levels in MRS (NCT02048969) | Yale University | 2014-06-01 |
| Effect of Rifaximine on Sleep Disorders in Patients Suffering From Hepatic Encephalopathy (NCT02163837) | Centre Hospitalier Universitaire Saint Pierre | 2014-03-01 |
| Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE) (NCT01966419) | Ocera Therapeutics, Inc. | 2014-01-07 |
| Quantitative Determination of Brain Water Content in Patients During and After Hepatic Encepalopathy (NCT02177708) | University of Aarhus | 2014-01-01 |
| L-ornithine L-aspartate in Overt Hepatic Encephalopathy (NCT01722578) | Dayanand Medical College and Hospital | 2013-12-01 |
| Brain Muscle Axis During Treatment of Hepatic Encephalopathy With L-ornithine L-aspartate (NCT01847651) | Imperial College London | 2013-08-01 |
| Glutamine Challenge as Predictor of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt (TIPS) (NCT02026609) | University of Arkansas | 2013-05-01 |
| ETOS: Minimal Hepatic Encephalopathy in Childhood and Young Adult: epidemiOlogical Study and Pilot Interventional Study (NCT01798329) | A.O. Ospedale Papa Giovanni XXIII | 2013-03-01 |
| Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.) (NCT01923376) | New York Presbyterian Brooklyn Methodist Hospital | 2013-02-01 |
| The Safety/Efficacy of Rifaximin With/Without Lactulose in Participants With A History of Recurrent Hepatic Encephalopathy (NCT01842581) | Bausch Health Americas, Inc. | 2013-01-08 |
| Diagnosis of Covert/Minimal Hepatic Encephalopathy by Means of Continuous Reaction Time Measurement (NCT01773538) | Mette Munk Lauridsen | 2013-01-01 |
| iPod Games in Hepatic Encephalopathy (NCT02154282) | Hunter Holmes Mcguire Veteran Affairs Medical Center | 2013-01-01 |
| Default Mode Network fMRI Maps as a Predictive Index of Hepatic Encephalopathy Outcome (NCT02083367) | OSF Healthcare System | 2013-01-01 |
| Effect of Music on Attention and Prospective Memory in Hepatic Encephalopathy (NCT01882855) | NYU Langone Health | 2012-12-01 |
| The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy. (NCT01846806) | NYU Langone Health | 2012-09-01 |
| Post Transjugular Intrahepatic Portosystemic Shunt (Tips) Albumine Infusion to Prevent Hepatic Encephalopathy (NCT01559519) | University of Roma La Sapienza | 2012-09-01 |
| Factors Associated With End Stage Liver Disease (NCT01846819) | NYU Langone Health | 2012-07-01 |
| The Effect of a Large-volume Paracentesis on Fatigue, Sleep, and Quality of Life in Cirrhosis (NCT01777971) | NYU Langone Health | 2012-07-01 |
| Efficacy of Sildenafil in the Improvement of Cognition and Quality of Life in Patients With Cirrhosis of Liver. A Proof of Concept Study. (NCT02028429) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2012-07-01 |
| Prediction of Mortality in Patients Waiting for Liver Transplantation Through Brain Magnetic Resonance Imaging (NCT01434056) | Hospital Israelita Albert Einstein | 2011-11-01 |
| S. Endotoxin, Inflammatory Mediators and MRS Before and After Treatment in MHE (NCT01446523) | Govind Ballabh Pant Hospital | 2011-10-01 |
| Effect of Tolvaptan on Cognitive Function in Cirrhosis (NCT01556646) | Hunter Holmes Mcguire Veteran Affairs Medical Center | 2011-04-01 |
| Monitoring of Encephalopathy in Cirrhotic Patients Admitted in Intensive Care (NCT01494064) | Assistance Publique - Hôpitaux de Paris | 2011-02-01 |
| Comparison Between Lactulose and Lactulose-Paraffin in Cirrhotic Patients (NCT02017119) | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 2011-01-01 |
| Efficacy Study of Polyethylene Glycol 3350-electrolyte Solution (GoLYTELY®) Versus Lactulose in Patients With Hepatic Encephalopathy. (NCT01283152) | University of Texas Southwestern Medical Center | 2011-01-01 |
| Trial Comparing Sedation for Endoscopy With Propofol Versus Midazolam in Cirrhotics (NCT01356121) | Govind Ballabh Pant Hospital | 2010-11-01 |
| Rifaximin Plus Lactulose Versus Lactulose Alone for the Treatment of Hepatic Encephalopathy: a Double Blind Randomized Trial (NCT01218568) | Institute of Liver and Biliary Sciences, India | 2010-10-01 |
| Cerebral Oxygen, Blood Flow and Ammonia Uptake in Patients With Cirrhosis and an Acute Episode of Hepatic Encephalopathy (HE) (NCT01151475) | University of Aarhus | 2010-08-01 |
| Effect of Lactose in Patients With Chronic Liver Disease and Minimal Hepatic Encephalopathy (NCT01113567) | Coordinación de Investigación en Salud, Mexico | 2010-07-01 |
| Secondary Prophylaxis of Hepatic Encephalopathy With a Probiotic Preparation (NCT01110447) | CD Pharma India Pvt. Ltd. | 2010-04-01 |
| Cerebrovascular Reactivity in Hepatic Encephalopathy (NCT01099293) | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 2010-03-01 |
| Study on B-blockers to Prevent Decompensation of Cirrhosis With HTPortal (NCT01059396) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2010-01-28 |
| A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy (NCT00999167) | Amgen | 2009-12-01 |
| Efficacy of L-Ornithine L-Aspartate in Acute Hepatic Encephalopathy. (NCT01041755) | Centro Regional para el Estudio de las Enfermedades Digestivas | 2009-11-01 |
| Effect of Probiotics in Treatment of Minimal Hepatic Encephalopathy (MHE) and Health Related Quality of Life (NCT01008293) | CD Pharma India Pvt. Ltd. | 2009-10-01 |
| Efficacy of Albumin for Acute Encephalopathy in Patients With Cirrhosis (NCT00886925) | Hospital Universitari Vall d'Hebron Research Institute | 2009-03-01 |